Molecular Basis of Human Enamel Defects
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mutational Analysis of Candidate Genes in 24 Amelogenesis
Eur J Oral Sci 2006; 114 (Suppl. 1): 3–12 Copyright Ó Eur J Oral Sci 2006 Printed in Singapore. All rights reserved European Journal of Oral Sciences Jung-Wook Kim1,2, James P. Mutational analysis of candidate genes Simmer1, Brent P.-L. Lin3, Figen Seymen4, John D. Bartlett5, Jan C.-C. in 24 amelogenesis imperfecta families Hu1 1University of Michigan School of Dentistry, University of Michigan Dental Research 2 Kim J-W, Simmer JP, Lin BP-L, Seymen F, Bartlett JD, Hu JC-C. Mutational analysis Laboratory, Ann Arbor, MI, USA; Seoul National University, College of Dentistry, of candidate genes in 24 amelogenesis imperfecta families. Eur J Oral Sci 2006; 114 Department of Pediatric Dentistry & Dental (Suppl. 1): 3–12 Ó Eur J Oral Sci, 2006 Research Institute, Seoul, Korea; 3UCSF School of Dentistry, Department of Growth and Amelogenesis imperfecta (AI) is a heterogeneous group of inherited defects in dental Development, San Francisco, CA, USA; 4 enamel formation. The malformed enamel can be unusually thin, soft, rough and University of Istanbul, Faculty of Dentistry, stained. The strict definition of AI includes only those cases where enamel defects Department of Pedodontics, apa, Istanbul, Turkey; 5The Forsyth Institute, Harvard-Forsyth occur in the absence of other symptoms. Currently, there are seven candidate genes for Department of Oral Biology, Boston, MA, USA AI: amelogenin, enamelin, ameloblastin, tuftelin, distal-less homeobox 3, enamelysin, and kallikrein 4. To identify sequence variations in AI candidate genes in patients with isolated enamel defects, and to deduce the likely effect of each sequence variation on Jan C.-C. -
Tooth Enamel and Its Dynamic Protein Matrix
International Journal of Molecular Sciences Review Tooth Enamel and Its Dynamic Protein Matrix Ana Gil-Bona 1,2,* and Felicitas B. Bidlack 1,2,* 1 The Forsyth Institute, Cambridge, MA 02142, USA 2 Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA 02115, USA * Correspondence: [email protected] (A.G.-B.); [email protected] (F.B.B.) Received: 26 May 2020; Accepted: 20 June 2020; Published: 23 June 2020 Abstract: Tooth enamel is the outer covering of tooth crowns, the hardest material in the mammalian body, yet fracture resistant. The extremely high content of 95 wt% calcium phosphate in healthy adult teeth is achieved through mineralization of a proteinaceous matrix that changes in abundance and composition. Enamel-specific proteins and proteases are known to be critical for proper enamel formation. Recent proteomics analyses revealed many other proteins with their roles in enamel formation yet to be unraveled. Although the exact protein composition of healthy tooth enamel is still unknown, it is apparent that compromised enamel deviates in amount and composition of its organic material. Why these differences affect both the mineralization process before tooth eruption and the properties of erupted teeth will become apparent as proteomics protocols are adjusted to the variability between species, tooth size, sample size and ephemeral organic content of forming teeth. This review summarizes the current knowledge and published proteomics data of healthy and diseased tooth enamel, including advancements in forensic applications and disease models in animals. A summary and discussion of the status quo highlights how recent proteomics findings advance our understating of the complexity and temporal changes of extracellular matrix composition during tooth enamel formation. -
Amelogenesis Imperfecta - Literature Review
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 13, Issue 1 Ver. IX. (Feb. 2014), PP 48-51 www.iosrjournals.org Amelogenesis Imperfecta - Literature Review GemimaaHemagaran1 ,Arvind. M2 1B.D.S.,Saveetha Dental College, Chennai, India 2B.D.S., M.D.S., Dip Oral medicine, Prof. of Oral Medicine, Saveetha Dental College, Chennai, India. Abstract: Amelogenesis Imperfecta (AI) is a group of inherited disorder of dental enamel formation in the absence of systemic manifestations. AI is also known as Hereditary enamel dysplasia, Hereditary brown enamel, Hereditary brown opalescent teeth. Since the mesodermal components of the teeth is normal, this defect is entirely ectodermal in origin. Variants of AI generally are classified as hypoplastic, hypocalcified, or hypomineralised types based on the primary enamel defect. The affected teeth may be discoloured, sensitive or prone to disintegration, leading to loss of occlusal vertical dimensions and very poor aesthetics. They exists in isolation or associated with other abnormalities in syndromes. It may show autosomal dominant, autosomal recessive, sex-linked and sporadic inheritance patterns. Mutations in the amelogenin, enamelin, and kallikrein-4 genes have been demonstrated to different types of AI. Keywords: AmelogenesisImperfecta, Hypoplastic, Hypocalcific, Hypomineralised. I. Introduction: Amelogenesis imperfecta (AI) is a term for a clinically and genetically heterogeneous group of conditions that affect the dental enamel, occasionally in conjunction with other dental, oral and extraoral tissues.[1] Dental enamel formation is divided into secretory, transition, and maturation stages. During the secretory stage, enamel crystals grow primarily in length. During the maturation stage, mineral is deposited exclusively on the sides of the crystallites, which grow in width and thickness to coalesce with adjacent crystals.[2]The main structural proteins in forming enamel are amelogenin, ameloblastin, and enamelin. -
Assessment Genetics Mutations in Genes AMELX, ENAM, MMP20 and FAM83H in Inducate Amelogenesis Imperfecta Syndrome Shahin Asadi*
Haematology Open Access Open Journal Review Assessment Genetics Mutations in Genes AMELX, ENAM, MMP20 and FAM83H in Inducate Amelogenesis Imperfecta Syndrome Shahin Asadi* Director of the Division of Medical Genetics and Molecular Research, Molecular Medicine, Genetics Harvard University, USA *Correspondence to: Shahin Asadi; Director of the Division of Medical Genetics and Molecular Research, Molecular Medicine, Genetics Harvard University, USA; E-mail: [email protected] Received: March 28th, 2019; Revised: March 29th, 2019; Accepted: March 29th, 2019; Published: March 30th, 2019 Citation: Carlos TJ, Ignacio HD, Xavier SI, Ariel LE. Assessment genetics mutations in genes AMELX,ENAM, MMP20 and FAM83H in inducate amelogenesis imperfecta syndrome. Haemat Open A Open J. 2019; I(1): 5-8. ABSTRACT Defective amelogenesis syndrome is a genetic disorder in the development of teeth. The researchers described at least 14 types of incomplete amelogenesis disorders. Mutations in the AMELX, ENAM, MMP20, and FAM83H genes can cause malformation of the amelogenesis syndrome. Keywords: Amelogenesis syndrome, AMELX, ENAM, MMP20, FAM83H genes, Teeth disorders.. GENERALIZATIONS OF INCOMPLETE AMELOGENESIS cific dental disorders and hereditary patterns. Additionally, incomplete SYNDROME amelogenesis syndrome can occur alone without any other symptoms or symptoms, or it can occur as part of a syndrome that affects different Defective amelogenesis syndrome is a genetic disorder in the develop- parts of the body.2 ment of teeth. This condition causes the teeth to be abnormally small, colored, pitted or perforated, and are prone to wear and breakage. Other Figure 2. Another view of dental disorders in amelogenesis syndrome dental disorders may also occur in incomplete amelogenesis syndrome. These defects, which vary among people affected, can affect the teeth (the child) and permanent teeth (adults).1 Figure 1. -
Discovery of Genes by Phylocsf Supplemental
Supplemental Materials for Discovery of high-confidence human protein-coding genes and exons by whole-genome PhyloCSF helps elucidate 118 GWAS loci Supplemental Methods ....................................................................................................................... 2 Supplemental annotation methods ........................................................................................................... 2 Manual annotation overview ...................................................................................................................................... 2 Summary diagram for the workflow used in this study ................................................................................. 3 Transcriptomics analysis ............................................................................................................................................. 3 Comparative annotation ............................................................................................................................................... 4 Overlap of novel annotations with transposon sequences ........................................................................... 6 Assessing the novelty of annotations ...................................................................................................................... 7 Additional considerations for the annotation of PCCRs in other species ............................................... 7 PhyloCSF and browser tracks .................................................................................................................... -
Protein Nanoribbons Template Enamel Mineralization
Protein nanoribbons template enamel mineralization Yushi Baia, Zanlin Yub, Larry Ackermana, Yan Zhangc, Johan Bonded,WuLic, Yifan Chengb, and Stefan Habelitza,1 aDepartment of Preventative and Restorative Dental Sciences, School of Dentistry, University of California, San Francisco, CA 94143; bDepartment of Biochemistry and Biophysics, School of Medicine, University of California, San Francisco, CA 94158; cDepartment of Oral and Craniofacial Sciences, School of Dentistry, University of California, San Francisco, CA 94143; and dDivision of Pure and Applied Biochemistry, Center for Applied Life Sciences, Lund University, Lund, SE-221 00, Sweden Edited by Patricia M. Dove, Virginia Tech, Blacksburg, VA, and approved July 2, 2020 (received for review April 22, 2020) As the hardest tissue formed by vertebrates, enamel represents early tissue-based transmission electron microscopy (TEM) nature’s engineering masterpiece with complex organizations of studies also show the presence of filamentous protein assemblies fibrous apatite crystals at the nanometer scale. Supramolecular (18–20) that share great structural similarity with the recombi- assemblies of enamel matrix proteins (EMPs) play a key role as nant amelogenin nanoribbons (7, 12). Even though previous the structural scaffolds for regulating mineral morphology during XRD and TEM characterizations suggest that nanoribbons may enamel development. However, to achieve maximum tissue hard- represent the structural nature of the in vivo observed filamen- ness, most organic content in enamel is digested and removed at tous proteins, they do not provide sufficient resolution to make the maturation stage, and thus knowledge of a structural protein detailed comparison. In addition, the filamentous proteins in the template that could guide enamel mineralization is limited at this DEM match the size and alignment of apatite crystal ribbons date. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Porcine Enamel Protein Fractions Contain Transforming Growth
Volume 77 • Number 10 Porcine Enamel Protein Fractions Contain Transforming Growth Factor-b1 Takatoshi Nagano,* Shinichiro Oida,† Shinichi Suzuki,* Takanori Iwata,‡ Yasuo Yamakoshi,‡ Yorimasa Ogata,§ Kazuhiro Gomi,* Takashi Arai,* and Makoto Fukae† Background: Enamel extracts are biologically active and capable of inducing osteogenesis and cementogenesis, but the specific molecules carrying these activities have not been as- certained. The purpose of this study was to identify osteogenic factors in porcine enamel extracts. Methods: Enamel proteins were separated by size-exclusion chromatography into four fractions, which were tested for their roteins extracted from the imma- osteogenic activity on osteoblast-like cells (ST2) and human ture enamel matrix of developing periodontal ligament (HPDL) cells. Pteeth possess important biologic Results: Fraction 3 (Fr.3) and a transforming growth factor- activities, such as the induction of osteo- beta 1 (TGF-b1) control reduced alkaline phosphatase (ALP) genesis1-3 and cementogenesis.4 For activity in ST2 but enhanced ALP activity in HPDL cells. The example, it was shown in in vivo and in enhanced ALP activity was blocked by anti-TGF-b antibodies. vitro systems that enamel matrix deriv- Furthermore, using a dual-luciferase reporter assay, we dem- atives (EMDs) have cementum- and onstrated that Fr.3 can induce the promoter activity of the osteopromotive activities5 and stimulate plasminogen activator inhibitor type 1 (PAI-1) gene. the proliferation and differentiation of Conclusion: These results show that the osteoinductive ac- osteoblastic cells.6 tivity of enamel extracts on HPDL cells is mediated by TGF-b1. In developing dental enamel, there are J Periodontol 2006;77:1688-1694. -
The Pitx2:Mir-200C/141:Noggin Pathway Regulates Bmp Signaling
3348 RESEARCH ARTICLE STEM CELLS AND REGENERATION Development 140, 3348-3359 (2013) doi:10.1242/dev.089193 © 2013. Published by The Company of Biologists Ltd The Pitx2:miR-200c/141:noggin pathway regulates Bmp signaling and ameloblast differentiation Huojun Cao1,*, Andrew Jheon2,*, Xiao Li1, Zhao Sun1, Jianbo Wang1, Sergio Florez1, Zichao Zhang1, Michael T. McManus3, Ophir D. Klein2,4 and Brad A. Amendt1,5,‡ SUMMARY The mouse incisor is a remarkable tooth that grows throughout the animal’s lifetime. This continuous renewal is fueled by adult epithelial stem cells that give rise to ameloblasts, which generate enamel, and little is known about the function of microRNAs in this process. Here, we describe the role of a novel Pitx2:miR-200c/141:noggin regulatory pathway in dental epithelial cell differentiation. miR-200c repressed noggin, an antagonist of Bmp signaling. Pitx2 expression caused an upregulation of miR-200c and chromatin immunoprecipitation assays revealed endogenous Pitx2 binding to the miR-200c/141 promoter. A positive-feedback loop was discovered between miR-200c and Bmp signaling. miR-200c/141 induced expression of E-cadherin and the dental epithelial cell differentiation marker amelogenin. In addition, miR-203 expression was activated by endogenous Pitx2 and targeted the Bmp antagonist Bmper to further regulate Bmp signaling. miR-200c/141 knockout mice showed defects in enamel formation, with decreased E-cadherin and amelogenin expression and increased noggin expression. Our in vivo and in vitro studies reveal a multistep transcriptional program involving the Pitx2:miR-200c/141:noggin regulatory pathway that is important in epithelial cell differentiation and tooth development. -
Amelogenesis Imperfecta
Amelogenesis imperfecta Description Amelogenesis imperfecta is a disorder of tooth development. This condition causes teeth to be unusually small, discolored, pitted or grooved, and prone to rapid wear and breakage. Other dental abnormalities are also possible. These defects, which vary among affected individuals, can affect both primary (baby) teeth and permanent (adult) teeth. Researchers have described at least 14 forms of amelogenesis imperfecta. These types are distinguished by their specific dental abnormalities and by their pattern of inheritance. Additionally, amelogenesis imperfecta can occur alone without any other signs and symptoms or it can occur as part of a syndrome that affects multiple parts of the body. Frequency The exact incidence of amelogenesis imperfecta is uncertain. Estimates vary widely, from 1 in 700 people in northern Sweden to 1 in 14,000 people in the United States. Causes Mutations in the AMELX, ENAM, MMP20, and FAM83H genes can cause amelogenesis imperfecta. The AMELX, ENAM, and MMP20 genes provide instructions for making proteins that are essential for normal tooth development. Most of these proteins are involved in the formation of enamel, which is the hard, calcium-rich material that forms the protective outer layer of each tooth. Although the function of the protein produced from the FAM83H gene is unknown, it is also believed to be involved in the formation of enamel. Mutations in any of these genes result in altered protein structure or prevent the production of any protein. As a result, tooth enamel is abnormally thin or soft and may have a yellow or brown color. Teeth with defective enamel are weak and easily damaged. -
Systems-Level Identification of PKA-Dependent Signaling In
Systems-level identification of PKA-dependent PNAS PLUS signaling in epithelial cells Kiyoshi Isobea, Hyun Jun Junga, Chin-Rang Yanga,J’Neka Claxtona, Pablo Sandovala, Maurice B. Burga, Viswanathan Raghurama, and Mark A. Kneppera,1 aEpithelial Systems Biology Laboratory, Systems Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1603 Edited by Peter Agre, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, and approved August 29, 2017 (received for review June 1, 2017) Gproteinstimulatoryα-subunit (Gαs)-coupled heptahelical receptors targets are as yet unidentified. Some of the known PKA targets regulate cell processes largely through activation of protein kinase A are other protein kinases and phosphatases, meaning that PKA (PKA). To identify signaling processes downstream of PKA, we de- activation is likely to result in indirect changes in protein phos- leted both PKA catalytic subunits using CRISPR-Cas9, followed by a phorylation manifest as a signaling network, the details of which “multiomic” analysis in mouse kidney epithelial cells expressing the remain unresolved. To identify both direct and indirect targets of Gαs-coupled V2 vasopressin receptor. RNA-seq (sequencing)–based PKA in mammalian cells, we used CRISPR-Cas9 genome editing transcriptomics and SILAC (stable isotope labeling of amino acids in to introduce frame-shifting indel mutations in both PKA catalytic cell culture)-based quantitative proteomics revealed a complete loss subunit genes (Prkaca and Prkacb), thereby eliminating PKA-Cα of expression of the water-channel gene Aqp2 in PKA knockout cells. and PKA-Cβ proteins. This was followed by use of quantitative SILAC-based quantitative phosphoproteomics identified 229 PKA (SILAC-based) phosphoproteomics to identify phosphorylation phosphorylation sites. -
Upregulation of 15 Antisense Long Non-Coding Rnas in Osteosarcoma
G C A T T A C G G C A T genes Article Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma Emel Rothzerg 1,2 , Xuan Dung Ho 3 , Jiake Xu 1 , David Wood 1, Aare Märtson 4 and Sulev Kõks 2,5,* 1 School of Biomedical Sciences, The University of Western Australia, Perth, WA 6009, Australia; [email protected] (E.R.); [email protected] (J.X.); [email protected] (D.W.) 2 Perron Institute for Neurological and Translational Science, QEII Medical Centre, Nedlands, WA 6009, Australia 3 Department of Oncology, College of Medicine and Pharmacy, Hue University, Hue 53000, Vietnam; [email protected] 4 Department of Traumatology and Orthopaedics, University of Tartu, Tartu University Hospital, 50411 Tartu, Estonia; [email protected] 5 Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, WA 6150, Australia * Correspondence: [email protected]; Tel.: +61-(0)-8-6457-0313 Abstract: The human genome encodes thousands of natural antisense long noncoding RNAs (lncR- NAs); they play the essential role in regulation of gene expression at multiple levels, including replication, transcription and translation. Dysregulation of antisense lncRNAs plays indispensable roles in numerous biological progress, such as tumour progression, metastasis and resistance to therapeutic agents. To date, there have been several studies analysing antisense lncRNAs expression profiles in cancer, but not enough to highlight the complexity of the disease. In this study, we investi- gated the expression patterns of antisense lncRNAs from osteosarcoma and healthy bone samples (24 tumour-16 bone samples) using RNA sequencing.